Remove 2019 Remove Eczema Remove Safety
article thumbnail

Review Study Aims to Refine Safety Profile of JAK Inhibitors in AD

The Dermatology Digest

The comprehensive safety analysis establishes evidence regarding the safety of systematic Janus kinase inhibitors in patients with atopic dermatitis. They reviewed the available safety data and analyzed the risk of 11 adverse events from 14 RCTs published between 2019 and 2022.

Safety 36
article thumbnail

FDA, EMA Accept Galderma’s BLA for Nemolizumab for PN and AD

The Dermatology Digest

This follows its designation as a Breakthrough Therapy for the treatment of pruritus associated with prurigo nodularis, originally granted in December 2019 and reconfirmed in March 2023. Nemolizumab was generally well tolerated and its safety profile was similar to placebo across the OLYMPIA and ARCADIA clinical trial programs.

article thumbnail

Review Study Aims to Refine Safety Profile of JAK Inhibitors in AD

The Dermatology Digest

They reviewed the available safety data and analyzed the risk of 11 adverse events from 14 RCTs published between 2019 and 2022. The post Review Study Aims to Refine Safety Profile of JAK Inhibitors in AD appeared first on The Dermatology Digest.

Safety 36
article thumbnail

Nemolizumab Update: Galderma’s IL-31 Blocker Continues to Wow in PN, AD

The Dermatology Digest

This follows its designation as a Breakthrough Therapy for the treatment of pruritus associated with prurigo nodularis, originally granted in December 2019 and reconfirmed in March 2023. No new safety signals were observed in this trial.

article thumbnail

2023 Sunscreen E-Summit Replay

The Eco Well Blog

John retired as Managing Director of Eurofins | Dermatest based in Sydney, Australia in June 2019, but remains in a part time consultancy role, specialising in sunscreens. He’s held key R&D, regulatory, quality, product safety, clinical & scientific affairs positions at Ciba, Dial, Henkel, ITG Brands, Newell Rubbermaid.

Legal 52
article thumbnail

Thinning Eyebrows in Women Over 40: Causes and Best Treatments

Alison Bladh

Skin Conditions Conditions like eczema, psoriasis, or seborrheic dermatitis can irritate the skin around the brows, leading to hair loss. Microblading: Safety and Efficacy in Eyebrow Enhancement. A deficiency in these can result in hair thinning across the scalp, lashes, and brows. J., & Stull, C. Lachgar, S., & Charveron, M.

article thumbnail

Can Estrogen Cream Reverse Skin Aging?

US Dermatologt Partners

In one review published in 2019 , researchers analyzed the results of about two dozen studies. Estrogen could also worsen any dark patches and discoloration or make blood vessels more apparent, she added; or it could aggravate skin conditions like eczema and rosacea, said Dr. Debra Jaliman, a dermatologist in New York City.